.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Alzheimer’s disease presents a significant challenge for modern medicine, creating an urgent need for neuroregenerative treatments. Recent research indicates that NeuroD1 gene therapy effectively repairs functional brain damage in non-human primate models. This innovative approach targets hippocampal degeneration, which typically leads to severe memory loss.
Scientists utilized an adeno-associated virus (AAV) vector to deliver the NeuroD1 gene into the hippocampus. Consequently, the therapy prevented neuronal damage and significantly reduced neuroinflammation. Moreover, researchers observed a restoration of the blood-brain barrier and vascular integrity. These improvements coincided with enhanced spatial working memory and stabilized hippocampal glucose metabolism.
The study employed advanced imaging, including MRI and FDG PET scans, to monitor brain changes. Results showed that the treatment inhibited hippocampal atrophy. Furthermore, transcriptome analysis confirmed the upregulation of neuronal function and synaptic transmission pathways. Because the primate model closely reflects human pathology, these findings offer substantial hope for future clinical applications.
It acts as a master transcription factor that facilitates the conversion of glial cells into functional neurons, thereby repairing damaged brain circuits.
The therapy restores CSF AD biomarker levels to more normal ranges, suggesting a systemic improvement in brain health and pathology.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Jiang Z et al. A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair in Alzheimer's Disease-Like Non-Human Primate Model. Adv Sci (Weinh). 2026 Mar 10. doi: 10.1002/advs.202520239. PMID: 41806359.
Ge L-J, et al. In vivo Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates. Front Cell Dev Biol. 2020;8:590008.
Chen YC, et al. A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion. Mol Ther. 2020;28(1):217-234.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research demonstrates that NeuroD1 AAV-based gene therapy repairs brain function, inhibits atrophy, and improves memory in Alzheimer's primate models....
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
